Hims & Hers (NYSE: HIMS) has been on a wild journey over the past year as GLP-1s drive both big gains and big losses for the ...

Fintel reports that on January 10, 2025, Citigroup downgraded their outlook for Hims & Hers Health (NYSE:HIMS) from Neutral ...

Hims & Hers Health (HIMS) stock gained after Citi upgraded the company, while agilon health (AGL) stock slipped after its downgrade. Read more here.

Hims & Hers reported impressive third-quarter results in November, with earnings of 32 cents per share, far exceeding analyst ...

Citi downgraded Hims & Hers to Sell from Neutral with a price target of $25, up from $24. The firm thinks the market is overvaluing the ...

In recent trading, shares of Hims & Hers Health Inc (Symbol: HIMS) have crossed above the average analyst 12-month target price of $25.36, changing hands for $26.63/share. When a stock reaches the ...

Hims & Hers Health Inc (HIMS) stock saw a modest uptick, ending the day at $27.67 which represents a slight increase of $0.77 or 2.86% from the prior close of $26.9. The stock opened at $27.68 and ...

Hims & Hers (NYSE:HIMS) has donated $1 million to President-elect Donald Trump's inaugural committee. The telehealth brand joins tech giants Meta (META), Amazon (AMZN) and OpenAI in donating seven ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Chad and Senegal on Tuesday hit back at comments made by President Macron claiming that African countries in the Sahel had ...

You can actually stave them off with one very simple solution, and that means kissing "Possible Spam" (without any legitimate name, of course) goodbye. And who hasn't wanted to do that in their ...